U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07340632) titled 'B4P Trial - BLOOM43 for Preconditioning' on Jan. 05.
Brief Summary: The goal of this clinical trial is to evaluate the use of the Plexaa preconditioning device (BLOOM43) in patients undergoing reconstructive breast surgery for breast cancer. This study aims to understand a participant's experience of the device, including its usability and acceptability.
Participants will use the device to precondition their breast the evening before undergoing surgery (mastectomy with immediate autologous and/or implant-based reconstruction).
Study Start Date: March 16
Study Type: INTERVENTIONAL
Condition:
Skin Necrosis
Breast Reconstruction
B...